Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Feature Articles
5/29/2023
National Value-based Pricing Negotiation for Oncology Drugs — Lessons...
5/29/2023
April Sees Deals Worth $2.8B in ADCs, CAR-T Therapies and More (Pharma...
5/26/2023
China's Souped-up Data Privacy Laws Deter Researchers (Nature)
5/26/2023
China's Middle Class – Growth, Policy, and Consumption (China Briefin...
5/22/2023
Doctor-influencers Ae Going Viral in China, Provoking Authorities (ROW...
5/19/2023
An AstraZeneca Executive Said the Quiet Part about China Out Loud (Qua...
5/19/2023
April Fundraising Rebounds with $315M Capital Injection to Hasten Biop...
5/19/2023
CStone Breaks Up With Drugs Partner As U.S. Rollout Stalls (Bamboo Wor...
5/16/2023
China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...
5/15/2023
China's $220 Billion Biotech Initiative Is Struggling to Take Off (Blo...
5/12/2023
How China's Population Decline Will Impact Doing Business in the Count...
5/11/2023
Lilly Migraine Deal Gives AffaMed New Mojo in Changing China: Video In...
5/11/2023
Ethical Review of Science and Technology in China: Draft Trial Measure...
5/9/2023
2023Q1 China Biopharma Ventures, IPOs and Deals (PharmaDJ)
5/5/2023
Reshoring and Nearshoring – Is China Still Relevant? (TMD)
5/4/2023
Hainan Allows Import of Urgently Needed Drugs and Medical Devices from...
5/4/2023
Does Chinese Tech Giant's AI Algorithm Hold the Key to Better mRNA Vac...
5/3/2023
New Report: China Cancer Antibodies Market Trends & Clinical Trials In...
5/3/2023
Getting Novel Drugs to China Through Special Zones (thepharmaletter)
5/3/2023
China Emerges as New APAC Pharma R&D Engine (BioSpectrum Asia/Citeline...
5/1/2023
Broad Economic Rebound Inspires Hope for Faster Recovery of Chinese Ph...
4/27/2023
Southeast Asia Is Becoming a Hot New Market for China's Innovative Dru...
4/26/2023
Why Rising Demand for Healthcare Is Creating Investment Opportunities ...
4/25/2023
Despite Strong Year-on-Year Growth in Q1, Licensing Deals Slow in Marc...
4/25/2023
Drug Licensing as Evidence of Evolution, Diffusion and Catch-up in Eas...
4/21/2023
AstraZeneca Oncology R&D Head On China Biotech Innovation - Looking Ag...
4/20/2023
Gene Editing: China's New Regulations Contain Concerning Loopholes, Ex...
4/20/2023
The US Is Relying More on China for Pharmaceuticals — and Vice Versa ...
4/20/2023
As Competition Heats Up, China PD-(L)1 Inhibitors Seek More Differenti...
4/19/2023
How Can Phase I Data from Western Medicine Accelerate Drug Development...
Page:
6
/
7
Total number of articles:
195
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit